Ascendis Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 8,335 | 0.0132% |
| Individual Insiders | 443,142 | 0.703% |
| Hedge Funds | 3,966,666 | 6.3% |
| VC/PE Firms | 10,108,400 | 16% |
| Institutions | 48,475,784 | 76.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 10,108,400 | US$1.3b | 0.01% | 18.48% | |||
| 5,671,934 | US$745.7m | -1.34% | 0.65% | |||
| 4,938,239 | US$649.3m | -3.44% | 0.04% | |||
| 4,350,829 | US$572.0m | -19.9% | 0.05% | |||
| 4,075,214 | US$535.8m | 1.11% | 3.06% | |||
| 3,966,666 | US$521.5m | 5.62% | 6.97% | |||
| 3,767,203 | US$495.3m | -5.7% | 0.22% | |||
| 2,745,872 | US$361.0m | -15.5% | 0.06% | |||
| 2,191,312 | US$288.1m | 0.46% | 0.02% | |||
| 1,617,830 | US$212.7m | 6.49% | 0.05% | |||
| 1,190,533 | US$156.5m | 12.4% | 0.06% | |||
| 962,910 | US$126.6m | 6.19% | 0.04% | |||
| 786,068 | US$103.4m | 8.33% | 0.12% | |||
| 754,032 | US$99.1m | 0% | 6.6% | |||
| 684,072 | US$89.9m | 35.2% | 0.12% | |||
| 614,107 | US$80.7m | 13.7% | 6.03% | |||
| 576,721 | US$75.8m | -2.2% | 4.63% | |||
| 575,698 | US$75.7m | -27.4% | 1.14% | |||
| 525,000 | US$69.0m | -16% | 6.46% | |||
| 507,952 | US$66.8m | 44.4% | 2.82% | |||
| 473,753 | US$62.3m | -19.6% | 0.02% | |||
| 457,504 | US$60.2m | 167% | 0.07% | |||
| 437,092 | US$57.5m | 3.37% | 0.03% | |||
| 423,279 | US$55.7m | 0% | no data | |||
| 405,169 | US$53.3m | 16.1% | no data |